Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$44.1B
1,086M shares
52-week range
$24.19 – $42.39
89% from low
Exchange
NYSE
ADRC
ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.
www.orix.co.jpNo one on the platform currently holds IX.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 109,600 | $3.3M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-31 | $0.3893 | 2026-06-10 |
| 2025-09-30 | $0.5987 | 2025-12-16 |
| 2025-03-31 | $0.4035 | 2025-06-11 |
| 2024-09-30 | $2.0574 | 2024-12-16 |
| 2024-03-27 | $1.7998 | 2024-06-11 |
| 2023-09-28 | $1.4781 | 2023-12-14 |
| Execution date | Ratio |
|---|---|
| 2025-02-28 | 5-for-1 |
No one on the platform has traded IX yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
https://www.marketbeat.com/earnings/reports/2026-8-6-orix-co-stock/ $IX Orix Corp Ads Earnings Transcript
View on StockTwits ↗$IX undiscovered breakout with 126 watchers
View on StockTwits ↗$IX $MCHP $CBRE $HUM $UAL ORIX expands financial services, Microchip Technology benefits from industrial semiconductor demand, CBRE leads commercial real estate services, Humana benefits from Medicare growth, and United Airlines continues travel recovery.
View on StockTwits ↗$HUM $IX $WDS $CRWV $HLN Humana benefits from Medicare growth, Orix expands financial services, Woodside Energy generates LNG cash flow, CRWV remains growth-oriented, and Haleon leads consumer healthcare products.
View on StockTwits ↗$HUM $IX $WDS $CRWV $HLN Humana benefits from Medicare growth, Orix expands financial services, Woodside Energy generates LNG cash flow, CRWV remains growth-oriented, and Haleon leads consumer healthcare products.
View on StockTwits ↗$IX undiscovered breakout with 126 watchers
View on StockTwits ↗$IX printed a new 52-week high today
View on StockTwits ↗$IX undiscovered breakout with 126 watchers
View on StockTwits ↗$IX undiscovered breakout with 126 watchers
View on StockTwits ↗$IX: ORIX Corporation issues Notice Regarding possible impact on ORIX Corporation's consolidated financial results, following Toshiba Corporation's full‑year financial results for the fiscal year ended March 31, 2026 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260521051528IX&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
View on StockTwits ↗$IX Price: $37.22 (+0.87%) Trend: Bullish Market Bias (7D): Bullish Bias 📈 Expected Range: ±2.00% RSI: 71.8 | Momentum: Strong Momentum Volume: -40.0% vs avg Volatility: 2.60% Support: $30.10 | Resistance: $38.56 Sourch: http://marketbaubles.com/
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-5-11-orix-co-stock/ $IX Orix Corp Ads Earnings Transcript
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $3.85T | +16.6% | $690.86 | $457.56–$922.65 | 0.1× | 1 |
| 2028 | $3.61T | -6.4% | $489.81 | $488.12–$509.72 | 0.1× | 1 |
| 2029 | $3.80T | +5.3% | $538.22 | $518.81–$560.10 | 0.1× | 1 |
| 2030 | $3.94T | +3.8% | $586.42 | $565.27–$610.26 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $1.16 | $1.57 | +35.3% |
| 2026-05-11 | $0.35 | $0.34 | -1.8% |
| 2026-02-09 | $0.51 | $0.69 | +35.8% |
| 2025-11-12 | $0.57 | $0.99 | +74.3% |
| 2025-08-07 | $0.54 | $0.65 | +20.4% |
| 2025-05-12 | $0.66 | $0.46 | -30.3% |
| 2025-02-10 | $0.02 | $0.51 | +2839.5% |
| 2024-11-08 | $0.50 |
| $0.56 |
| +12.0% |
| $22.8B |
| — |
| MSMorgan Stanley | $218.38 | +0.34% | $344.4B | — |
| MTBM&T Bank Corporation | $253.25 | -0.12% | $36.7B | — |
Source: Financial Modeling Prep · peers by sector/industry